Chwilio Deddfwriaeth

Health Act 2009

 Help about what version

Pa Fersiwn

 Help about advanced features

Nodweddion Uwch

 Help about opening options

Dewisiadau AgorExpand opening options

Changes over time for: Section 26

 Help about opening options

Alternative versions:

Status:

Point in time view as at 01/09/2012.

Changes to legislation:

Health Act 2009, Section 26 is up to date with all changes known to be in force on or before 27 February 2025. There are changes that may be brought into force at a future date. Changes that have been made appear in the content and are referenced with annotations. Help about Changes to Legislation

26New arrangements for entry to pharmaceutical listE+W

This adran has no associated Nodiadau Esboniadol

(1)Section 129 of the National Health Service Act 2006 (regulations as to pharmaceutical services) is amended as follows.

(2)In subsection (2)(c), for the words from “may be granted” to “specified in the application,” substitute “ must be granted if the Primary Care Trust is satisfied as mentioned in subsection (2A), and may otherwise be granted only if the Primary Care Trust is satisfied as mentioned in subsection (2B), ”.

(3)After subsection (2) insert—

(2A)The Primary Care Trust is satisfied as mentioned in this subsection if, having regard to its needs statement and to any matters prescribed by the Secretary of State in the regulations, it is satisfied that it is necessary to grant the application in order to meet a need in its area for the services or some of the services specified in the application.

(2B)The Primary Care Trust is satisfied as mentioned in this subsection if, having regard to its needs statement and to any matters prescribed by the Secretary of State in the regulations, it is satisfied that to grant the application would secure improvements, or better access, to pharmaceutical services in its area.

(2C)In relation to cases where the Primary Care Trust is satisfied as mentioned in subsection (2B), the regulations may make provision as to—

(a)the manner in which the Primary Care Trust is to determine whether to grant the application,

(b)matters which the Primary Care Trust must or must not take into account for the purpose of determining whether to grant the application.

(4)After subsection (3) insert—

(3A)The regulations may prescribe circumstances in which two or more applications referred to in subsection (2)(c)(i) or (ii) may be considered together by the Primary Care Trust.

(5)In subsection (4)—

(a)for the words from “include” to “subsection (5) for” substitute “ make provision for the Primary Care Trust to take into account prescribed matters in ”;

(b)omit paragraph (a);

(c)in paragraph (b), for “they” substitute “ two or more applications referred to in subsection (2)(c)(i) or (ii) ”;

(d)in paragraph (c), for “subsection (2)(c)” substitute “ subsection (2A) or (2B) ”.

(6)After subsection (4) insert—

(4A)Regulations under subsection (4) may in particular make the provision mentioned in subsection (5), with or without modifications.

(7)In subsection (6), before paragraph (a) insert—

(za)for the circumstances and manner in which a Primary Care Trust may invite applications for inclusion in a pharmaceutical list,.

(8)After subsection (10) insert—

(10A)Primary Care Trusts must give reasons for decisions made by virtue of this section.

(10B)In this section a “needs statement” means the statement required by section 128A(1)(b) as most recently published by the relevant Primary Care Trust.

Commencement Information

I1S. 26 in force at 1.9.2012 by S.I. 2012/1902, art. 2(a)

Yn ôl i’r brig

Options/Cymorth